Publications by authors named "Jonathan P Hatcher"

Claim this Profile
B
Biologics: the next-generation therapeutics for analgesia?
Jonathan P Hatcher, Iain P Chessell, Jane P Hughes

Expert Rev Neurother· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic drugs for analgesia: redefining the opportunity.
Jane Hughes, Jonathan P Hatcher, Iain P Chessell

Curr Pharm Biotechnol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of P2X₇ in pain and inflammation.
Jane P Hughes, Jonathan P Hatcher, Iain P Chessell

Purinergic Signal· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgenic models of pain: a brief review.
Jonathan P Hatcher, Iain P Chessell

Curr Opin Investig Drugs· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain.
Iain P Chessell, Jonathan P Hatcher, Chas Bountra, Anton D Michel, Jane P Hughes

Pain· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.
Sharon Bingham, Paul J Beswick, Chas Bountra, Terry Brown, Ian B Campbell, Jonathan P Hatcher

J Pharmacol Exp Ther· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis